Literature DB >> 23024837

Turning scar into muscle.

Antonio Carlos Campos de Carvalho1, Adriana Bastos Carvalho.   

Abstract

After the demonstration that somatic cells could be reprogrammed to a pluripotent state, exciting new prospects were opened for the cardiac regeneration field. It did not take long for the development of strategies to convert somatic cells directly into cardiomyocytes. Despite the intrinsic difficulties of cell reprogramming, such as low efficiency, the therapeutic possibilities created by the ability to turn scar into muscle are enormous. Here, we discuss some of the major advances and strategies used in direct cardiac reprogramming and examine discrepancies and concerns that still need to be resolved in the field.

Entities:  

Keywords:  Cardiac regeneration; Cardiomyocytes; Direct reprogramming; Induced pluripotent stem cells; microRNAs

Year:  2012        PMID: 23024837      PMCID: PMC3460220          DOI: 10.4330/wjc.v4.i9.267

Source DB:  PubMed          Journal:  World J Cardiol


  13 in total

1.  Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells.

Authors:  Bryce W Carey; Styliani Markoulaki; Jacob H Hanna; Dina A Faddah; Yosef Buganim; Jongpil Kim; Kibibi Ganz; Eveline J Steine; John P Cassady; Menno P Creyghton; G Grant Welstead; Qing Gao; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2011-12-02       Impact factor: 24.633

2.  Labor pains of new technology: direct cardiac reprogramming.

Authors:  Yoshinori Yoshida; Shinya Yamanaka
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

3.  MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes.

Authors:  Tilanthi M Jayawardena; Bakytbek Egemnazarov; Elizabeth A Finch; Lunan Zhang; J Alan Payne; Kumar Pandya; Zhiping Zhang; Paul Rosenberg; Maria Mirotsou; Victor J Dzau
Journal:  Circ Res       Date:  2012-04-26       Impact factor: 17.367

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.

Authors:  Masaki Ieda; Ji-Dong Fu; Paul Delgado-Olguin; Vasanth Vedantham; Yohei Hayashi; Benoit G Bruneau; Deepak Srivastava
Journal:  Cell       Date:  2010-08-06       Impact factor: 41.582

6.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

7.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

8.  In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.

Authors:  Li Qian; Yu Huang; C Ian Spencer; Amy Foley; Vasanth Vedantham; Lei Liu; Simon J Conway; Ji-dong Fu; Deepak Srivastava
Journal:  Nature       Date:  2012-05-31       Impact factor: 49.962

9.  Direct conversion of fibroblasts to functional neurons by defined factors.

Authors:  Thomas Vierbuchen; Austin Ostermeier; Zhiping P Pang; Yuko Kokubu; Thomas C Südhof; Marius Wernig
Journal:  Nature       Date:  2010-01-27       Impact factor: 49.962

10.  In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

Authors:  Qiao Zhou; Juliana Brown; Andrew Kanarek; Jayaraj Rajagopal; Douglas A Melton
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

View more
  1 in total

1.  Controlling networks of nonlinearly-coupled nodes using response surfaces.

Authors:  Jason Shulman; Franck Malatino; Alexander Mo; Killian Ryan; Gemunu H Gunaratne
Journal:  Sci Rep       Date:  2014-12-19       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.